Study of SHR6390 in Renal Insufficiency and Healthy Subjects
Status:
Not yet recruiting
Trial end date:
2023-09-28
Target enrollment:
Participant gender:
Summary
The study is a single-center, open, single-dose, self-controlled clinical trial. It is
planned to enroll 24-30 subjects.
Subjects will take the SHR6390 on Day1.